Search

Search results

90 results found

Computed tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates

Publication: Journal Article

Naninck, Thibaut, Nidhal Kahlaoui, Julien Lemaitre, Pauline Maisonnasse, Antoine De Mori, Quentin Pascal, Vanessa Contreras, et al. 2022. “Computed Tomography and [18F]-FDG PET Imaging Provide Additional Readouts for COVID-19 Pathogenesis and Therapies Evaluation in Non-Human Primates”. IScience 25 (4): 104101.

Neurodevelopmental disorders and somatic diagnoses in a national cohort of children born before 24 weeks of gestation

Publication: Journal Article

Morsing, Eva, Pia Lundgren, Anna-Lena Hård, Alexander Rakow, Lena Hellström-Westas, Lena Jacobson, Mats Johnson, et al. 2022. “Neurodevelopmental Disorders and Somatic Diagnoses in a National Cohort of Children Born before 24 Weeks of Gestation”. Acta Paediatr 111 (6): 1167-75.

Birdshot Chorioretinopathy: Resistant versus Responsive

Publication: Journal Article

Maleki, Arash, Sydney Look-Why, Ambika Manhapra, Soheila Asgari, Cristina Garcia, Alaa Al-Dabbagh, Catherine Tsang, Peter Chang, Stephen Anesi, and Stephen Foster. 2022. “Birdshot Chorioretinopathy: Resistant versus Responsive”. Ocul Immunol Inflamm, 1-6.

Treatment and Outcomes for IRDs

Page

Until the approval of Luxturna®, there were no definitive treatments for any IRDs. Today, with the success of Luxturna®, preliminary results from therapies currently under investigation, and an expanding therapeutic toolkit, we have good reason for optimism. We envision a future in which gene...

Applications and Referrals

Page

Applications to Other Diseases The same types of genetic strategies currently being tested for IRDs are also being tested and beginning to receive regulatory approvals in other areas of medicine. For example, the FDA has approved both gene-augmentation therapy and antisense oligonucleotide therapy...

Massachusetts Life Sciences Center announces capital funding to support innovation infrastructure- HMS Center for Glycoscience, NCFG, Glycomics Core recipients of funds

News: March 04, 2022

Massachusetts Life Sciences Center awards HMS Center for Glycoscience, the NCFG and the Glycomics Core at BIDMC $1.4 million for project titled " Innovative Glycoscience for Diagnostic and Therapeutic Advances". “This incredible support by the Massachusetts Life Sciences Center is vital to the...

Talk on haplotype-informed CNV analysis at ProbGen 2022

News: March 16, 2022

At the 2022 Probabilistic Modeling in Genomics (ProbGen) conference, Margaux Hujoel will be presenting her work on haplotype-informed CNV detection and subsequent association and fine-mapping analysis in UK Biobank: "Influences of rare copy number variation on human complex traits" (Mon Mar 28).

Five Medical Students Match into Harvard Combined OHNS Residency Program

News: March 18, 2022

We are pleased to introduce the five medical students who matched in the Harvard Combined Residency Program in Otolaryngology–Head and Neck Surgery this year. We hope that you will join us in welcoming them to Mass Eye and Ear, Brigham and Women's Hospital and Boston Children's Hospital this June...

2022 Spring Scientific Symposium

Page

HDDC Spring Symposium – Tuesday, June 7, 2022 Enders Building Folkman Auditorium (In person) and Virtually 9am – 5 PM 9-9:15am Welcome and introduction Sensory-motor regulation of gut functions 9:15-9:45AM Irene Miguel Aliaga (MRC – Imperial College London) 9:45-10:15AM Amber Alhadeff 10:15-10:30...

Dr. Gerburg Wulf, a 2022 ASCO WWCC Mentorship Award nominee

News: March 30, 2022

Dr Wulf, one of Dr Heng's mentor at BIDMC, has been recognised as a nominee for the 2022 ASCO Women Who Conquer Cancer (WWCC) Mentorship Award. https://www.conquer.org/news/conquer-cancer-announces-2022-wwcc-mentorsh... This is a well-deserved achivement for Dr. Wulf. She is an outstanding female...